Cargando…
Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells
Pyruvate kinase M2 (PKM2), as the terminal and last rate-limiting enzyme of the glycolytic pathway, is an ideal enzyme for regulating metabolic phenotype. PKM2 tetramer activation has shown a protective role against diabetic kidney disease (DKD). However, the molecular mechanisms involved in diabeti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471676/ https://www.ncbi.nlm.nih.gov/pubmed/36120453 http://dx.doi.org/10.3389/fendo.2022.965379 |
_version_ | 1784789134539227136 |
---|---|
author | Wang, Zhimin Yu, Jiating Hao, Dan Liu, Xin Wang, Xiao |
author_facet | Wang, Zhimin Yu, Jiating Hao, Dan Liu, Xin Wang, Xiao |
author_sort | Wang, Zhimin |
collection | PubMed |
description | Pyruvate kinase M2 (PKM2), as the terminal and last rate-limiting enzyme of the glycolytic pathway, is an ideal enzyme for regulating metabolic phenotype. PKM2 tetramer activation has shown a protective role against diabetic kidney disease (DKD). However, the molecular mechanisms involved in diabetic tubular have not been investigated so far. In this study, we performed transcriptome gene expression profiling in human renal proximal tubular epithelial cell line (HK-2 cells) treated with 25 mM high D-glucose (HG) for 7 days before the addition of 10 μM TEPP-46, an activator of PKM2 tetramerization, for a further 1 day in the presence of HG. Afterwards, we analyzed the differentially expressed (DE) genes and investigated gene relationships based on weighted gene co-expression network analysis. The results showed that 2,902 DE genes were identified (adjusted P-value ≤ 0.05), where 2,509 DE genes (86.46%) were co-expressed in the key module. Four extremely downregulated DE genes (HSPA8, HSPA2, HSPA1B, and ARRB1) and three extremely upregulated DE genes (GADD45A, IGFBP3, and SIAH1) enriched in the downregulated endocytosis (hsa04144) and upregulated p53 signaling pathway (hsa04115), respectively, were validated by qRT-PCR experiments. The qRT-PCR results showed that the relative expression levels of HSPA8 [adjusted P-value = 4.45 × 10(-34) and log(2)(FC) = -1.12], HSPA2 [adjusted P-value = 6.09 × 10(-14) and log(2)(FC) = -1.27], HSPA1B [adjusted P-value = 1.14 × 10(-11) and log(2)(FC) = -1.02], and ARRB1 [adjusted P-value = 2.60 × 10(-5) and log(2)(FC) = -1.13] were significantly different (P-value < 0.05) from the case group to the control group. Furthermore, the interactions and predicted microRNAs of the key genes (HSPA8, HSPA2, HSPA1B, and ARRB1) were visualized in networks. This study identified the key candidate transcriptomic biomarkers and biological pathways in hyperglycemic HK-2 cells responding to the PKM2 activator TEPP-46 that can highlight a possibility of PKM2 tetramerization reshaping the interplay among endocytic trafficking through the versatile networks of Hsp70s and rewiring the crosstalk between EGFR signal transduction circuits and metabolic stress to promote resilience, which will be valuable for further research on PKM2 in DKD. |
format | Online Article Text |
id | pubmed-9471676 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94716762022-09-15 Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells Wang, Zhimin Yu, Jiating Hao, Dan Liu, Xin Wang, Xiao Front Endocrinol (Lausanne) Endocrinology Pyruvate kinase M2 (PKM2), as the terminal and last rate-limiting enzyme of the glycolytic pathway, is an ideal enzyme for regulating metabolic phenotype. PKM2 tetramer activation has shown a protective role against diabetic kidney disease (DKD). However, the molecular mechanisms involved in diabetic tubular have not been investigated so far. In this study, we performed transcriptome gene expression profiling in human renal proximal tubular epithelial cell line (HK-2 cells) treated with 25 mM high D-glucose (HG) for 7 days before the addition of 10 μM TEPP-46, an activator of PKM2 tetramerization, for a further 1 day in the presence of HG. Afterwards, we analyzed the differentially expressed (DE) genes and investigated gene relationships based on weighted gene co-expression network analysis. The results showed that 2,902 DE genes were identified (adjusted P-value ≤ 0.05), where 2,509 DE genes (86.46%) were co-expressed in the key module. Four extremely downregulated DE genes (HSPA8, HSPA2, HSPA1B, and ARRB1) and three extremely upregulated DE genes (GADD45A, IGFBP3, and SIAH1) enriched in the downregulated endocytosis (hsa04144) and upregulated p53 signaling pathway (hsa04115), respectively, were validated by qRT-PCR experiments. The qRT-PCR results showed that the relative expression levels of HSPA8 [adjusted P-value = 4.45 × 10(-34) and log(2)(FC) = -1.12], HSPA2 [adjusted P-value = 6.09 × 10(-14) and log(2)(FC) = -1.27], HSPA1B [adjusted P-value = 1.14 × 10(-11) and log(2)(FC) = -1.02], and ARRB1 [adjusted P-value = 2.60 × 10(-5) and log(2)(FC) = -1.13] were significantly different (P-value < 0.05) from the case group to the control group. Furthermore, the interactions and predicted microRNAs of the key genes (HSPA8, HSPA2, HSPA1B, and ARRB1) were visualized in networks. This study identified the key candidate transcriptomic biomarkers and biological pathways in hyperglycemic HK-2 cells responding to the PKM2 activator TEPP-46 that can highlight a possibility of PKM2 tetramerization reshaping the interplay among endocytic trafficking through the versatile networks of Hsp70s and rewiring the crosstalk between EGFR signal transduction circuits and metabolic stress to promote resilience, which will be valuable for further research on PKM2 in DKD. Frontiers Media S.A. 2022-08-31 /pmc/articles/PMC9471676/ /pubmed/36120453 http://dx.doi.org/10.3389/fendo.2022.965379 Text en Copyright © 2022 Wang, Yu, Hao, Liu and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Wang, Zhimin Yu, Jiating Hao, Dan Liu, Xin Wang, Xiao Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells |
title | Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells |
title_full | Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells |
title_fullStr | Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells |
title_full_unstemmed | Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells |
title_short | Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells |
title_sort | transcriptomic signatures responding to pkm2 activator tepp-46 in the hyperglycemic human renal proximal epithelial tubular cells |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471676/ https://www.ncbi.nlm.nih.gov/pubmed/36120453 http://dx.doi.org/10.3389/fendo.2022.965379 |
work_keys_str_mv | AT wangzhimin transcriptomicsignaturesrespondingtopkm2activatortepp46inthehyperglycemichumanrenalproximalepithelialtubularcells AT yujiating transcriptomicsignaturesrespondingtopkm2activatortepp46inthehyperglycemichumanrenalproximalepithelialtubularcells AT haodan transcriptomicsignaturesrespondingtopkm2activatortepp46inthehyperglycemichumanrenalproximalepithelialtubularcells AT liuxin transcriptomicsignaturesrespondingtopkm2activatortepp46inthehyperglycemichumanrenalproximalepithelialtubularcells AT wangxiao transcriptomicsignaturesrespondingtopkm2activatortepp46inthehyperglycemichumanrenalproximalepithelialtubularcells |